News about GMP/cGMP


FDA: New Acting Commissioner Named

One week after the surprising resignation of FDA Commissioner Scott Gottlieb, Norman E. Sharpless, Director of the National Cancer Institute (NCI), was appointed Deputy Commissioner of the FDA, according to media reports.

The announcement was confirmed by Health and Social Affairs Minister Alex Azar at a Congress hearing on 12 March 2019.

Sharpless has been director of the NCI since October 2017. Previously, he was director of the Lineberger Comprehensive Cancer Center at the University of North Carolina (UNC) and served in the medical and genetics departments of the faculties of Harvard Medical School and the University of North Carolina School of Medicine.




Washington Post

NCI: Biography